| Q39227159 | A study in contrasts: eligibility criteria in a twenty-year sample of NSABP and POG clinical trials. National Surgical Adjuvant Breast and Bowel Program. Pediatric Oncology Group |
| Q37119507 | Barriers and facilitators for clinical trial participation among diverse Asian patients with breast cancer: a qualitative study |
| Q35642930 | Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review |
| Q37696455 | Comparison of survival outcomes among cancer patients treated in and out of clinical trials |
| Q51943059 | Generalizability of cancer clinical trial results: prognostic differences between participants and nonparticipants. |
| Q67930709 | Low dose cytosine arabinoside in the treatment of myeloid leukaemias and myelodysplastic syndromes |
| Q24245601 | Outcomes of patients who participate in randomised controlled trials compared to similar patients receiving similar interventions who do not participate |
| Q24242288 | Outcomes of patients who participate in randomized controlled trials compared to similar patients receiving similar interventions who do not participate |
| Q34278939 | The breast cancer research scandal: addressing the issues. |
| Q36080695 | Treatment of multiple myeloma according to the extension of the disease: a prospective, randomised study comparing a less with a more aggressive cystostatic policy. Cooperative Group of Study and Treatment of Multiple Myeloma |
| Q36621356 | Treatment, long-term outcome and prognostic variables in 214 unselected AML patients in Sweden |